507 related articles for article (PubMed ID: 24012083)
1. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
Kranzler HN; Cohen SD
Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
[TBL] [Abstract][Full Text] [Related]
2. Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children.
Lee ES; Kronsberg H; Findling RL
Child Adolesc Psychiatr Clin N Am; 2020 Jan; 29(1):183-210. PubMed ID: 31708047
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
[TBL] [Abstract][Full Text] [Related]
4. Side effects of antipsychotics in the elderly.
Masand PS
J Clin Psychiatry; 2000; 61 Suppl 8():43-9; discussion 50-1. PubMed ID: 10811243
[TBL] [Abstract][Full Text] [Related]
5. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.
Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892
[TBL] [Abstract][Full Text] [Related]
6. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Clozapine: more side effects but still the best antipsychotic.
Kang X; Simpson GM
J Clin Psychiatry; 2010 Aug; 71(8):982-3. PubMed ID: 20797378
[No Abstract] [Full Text] [Related]
9. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.
Vitiello B; Correll C; van Zwieten-Boot B; Zuddas A; Parellada M; Arango C
Eur Neuropsychopharmacol; 2009 Sep; 19(9):629-35. PubMed ID: 19467582
[TBL] [Abstract][Full Text] [Related]
10. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
Constantine RJ; Andel R; McPherson M; Tandon R
Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
12. New findings on antipsychotic use in children and adolescents with schizophrenia spectrum disorders.
Ross RG
Am J Psychiatry; 2008 Nov; 165(11):1369-72. PubMed ID: 18981065
[No Abstract] [Full Text] [Related]
13. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
Zuddas A; Zanni R; Usala T
Eur Neuropsychopharmacol; 2011 Aug; 21(8):600-20. PubMed ID: 21550212
[TBL] [Abstract][Full Text] [Related]
14. Update and recommendations for the use of antipsychotics in early-onset psychoses.
Bryden KE; Carrey NJ; Kutcher SP
J Child Adolesc Psychopharmacol; 2001; 11(2):113-30. PubMed ID: 11436951
[TBL] [Abstract][Full Text] [Related]
15. Off-Label Use of Clozapine in Children and Adolescents-A Literature Review.
Rachamallu V; Elberson BW; Vutam E; Aligeti M
Am J Ther; 2019; 26(3):e406-e416. PubMed ID: 31082865
[TBL] [Abstract][Full Text] [Related]
16. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
17. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
18. Evidence base for using atypical antipsychotics for psychosis in adolescents.
Datta SS; Kumar A; Wright SD; Furtado VA; Russell PS
Schizophr Bull; 2014 Mar; 40(2):252-4. PubMed ID: 24361758
[TBL] [Abstract][Full Text] [Related]
19. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
Maayan L; Correll CU
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of antipsychotic treatment in young patients with schizophrenia.
Correll CU
J Clin Psychiatry; 2011 Aug; 72(8):e26. PubMed ID: 21899814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]